Trial intelligence / Profile preview

Amniogen vs PRP in Knee Osteoarthritis

NCT04698265Unknown

Sponsor
Kaohsiung Veterans General Hospital
Start
Jan 2021
Primary completion
Jan 2022
Modality
Implantable Devices, Implantable Hydrogels
01

Overview

Randomised, double-blind trial of AMNIOGEN in osteoarthritis (OA) (4 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Western Ontario and McMaster Universities Arthritis Index at 12 months. Status: unknown.

02

Drugs

AMNIOGEN
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04698265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04698265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call